IOVA
$13.62-7.47%
Iovance Biotherapeutics Inc.Stock · HealthcareRussell 2000 0.05%Nasdaq Composite 0.005%US Stock Market 0.002%Russell 3000 0.001%
Iovance Biotherapeutics Inc. monthly returns
Iovance Biotherapeutics Inc. has averaged 3.19% per month, positive in 44% of months. Month-by-month returns for Iovance Biotherapeutics Inc. (IOVA) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Average month
+3.2%
190 months
Best month
+250.0%
Jul 2013
Worst month
-66.7%
Apr 2013
Positive months
44%
of all months
Iovance Biotherapeutics Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -8.1% | |
| Sep 2026 | +81.4% | |
| Aug 2026 | +100.7% | |
| Jul 2026 | -2.2% | |
| Jun 2026 | +1.5% | |
| May 2026 | +22.0% | |
| Apr 2026 | -4.3% | |
| Mar 2026 | -9.1% | |
| Feb 2026 | +51.4% | |
| Jan 2026 | -6.6% | |
| Dec 2025 | +10.5% | |
| Nov 2025 | +25.4% | |
| Oct 2025 | -9.2% | |
| Sep 2025 | -2.7% | |
| Aug 2025 | -13.2% | |
| Jul 2025 | +49.4% | |
| Jun 2025 | -1.7% | |
| May 2025 | -51.3% | |
| Apr 2025 | +7.8% | |
| Mar 2025 | -21.5% | |
| Feb 2025 | -27.5% | |
| Jan 2025 | -20.9% | |
| Dec 2024 | -20.6% | |
| Nov 2024 | -10.7% | |
| Oct 2024 | +11.2% | |
| Sep 2024 | -19.5% | |
| Aug 2024 | +33.6% | |
| Jul 2024 | +8.9% | |
| Jun 2024 | -9.7% | |
| May 2024 | -24.6% | |
| Apr 2024 | -20.5% | |
| Mar 2024 | -6.9% | |
| Feb 2024 | +105.8% | |
| Jan 2024 | -4.9% | |
| Dec 2023 | +33.9% | |
| Nov 2023 | +58.9% | |
| Oct 2023 | -16.0% | |
| Sep 2023 | -24.7% | |
| Aug 2023 | -16.8% | |
| Jul 2023 | +3.1% | |
| Jun 2023 | -19.5% | |
| May 2023 | +55.0% | |
| Apr 2023 | -7.7% | |
| Mar 2023 | -16.2% | |
| Feb 2023 | -8.4% | |
| Jan 2023 | +24.6% | |
| Dec 2022 | -0.2% | |
| Nov 2022 | -31.5% | |
| Oct 2022 | -2.5% | |
| Sep 2022 | -10.6% | |
| Aug 2022 | -8.0% | |
| Jul 2022 | +5.5% | |
| Jun 2022 | +63.6% | |
| May 2022 | -55.4% | |
| Apr 2022 | -9.0% | |
| Mar 2022 | +6.3% | |
| Feb 2022 | -5.9% | |
| Jan 2022 | -12.8% | |
| Dec 2021 | +2.0% | |
| Nov 2021 | -23.0% | |
| Oct 2021 | -1.4% | |
| Sep 2021 | +2.5% | |
| Aug 2021 | +8.1% | |
| Jul 2021 | -14.4% | |
| Jun 2021 | +40.1% | |
| May 2021 | -40.9% | |
| Apr 2021 | -0.7% | |
| Mar 2021 | -15.1% | |
| Feb 2021 | -14.9% | |
| Jan 2021 | -5.5% | |
| Dec 2020 | +19.6% | |
| Nov 2020 | +8.8% | |
| Oct 2020 | +8.4% | |
| Sep 2020 | -1.2% | |
| Aug 2020 | +14.7% | |
| Jul 2020 | +5.9% | |
| Jun 2020 | -14.5% | |
| May 2020 | -0.2% | |
| Apr 2020 | +7.4% | |
| Mar 2020 | -9.0% | |
| Feb 2020 | +51.4% | |
| Jan 2020 | -21.5% | |
| Dec 2019 | +21.2% | |
| Nov 2019 | +8.0% | |
| Oct 2019 | +16.1% | |
| Sep 2019 | -13.4% | |
| Aug 2019 | -14.6% | |
| Jul 2019 | +0.3% | |
| Jun 2019 | +50.0% | |
| May 2019 | +43.4% | |
| Apr 2019 | +19.9% | |
| Mar 2019 | -7.4% | |
| Feb 2019 | +12.2% | |
| Jan 2019 | +3.4% | |
| Dec 2018 | -8.5% | |
| Nov 2018 | +6.5% | |
| Oct 2018 | -19.3% | |
| Sep 2018 | -36.4% | |
| Aug 2018 | +24.6% | |
| Jul 2018 | +10.9% | |
| Jun 2018 | -12.3% | |
| May 2018 | +0.7% | |
| Apr 2018 | -14.2% | |
| Mar 2018 | -2.6% | |
| Feb 2018 | +11.6% | |
| Jan 2018 | +94.4% | |
| Dec 2017 | -11.6% | |
| Nov 2017 | +16.3% | |
| Oct 2017 | +0.4% | |
| Sep 2017 | +34.8% | |
| Aug 2017 | -1.7% | |
| Jul 2017 | -20.4% | |
| Jun 2017 | +42.7% | |
| May 2017 | -24.8% | |
| Apr 2017 | -8.1% | |
| Mar 2017 | -2.6% | |
| Feb 2017 | +5.5% | |
| Jan 2017 | +4.3% | |
| Dec 2016 | +4.5% | |
| Nov 2016 | +6.4% |
Monthly total return (since Nov 2021)#
-100%-50%0%50%100%
Nov 2021-23%
Dec 2021+2.0%
Jan 2022-13%2022
Feb 2022-5.9%
Mar 2022+6.3%
Apr 2022-9.0%
May 2022-55%
Jun 2022+64%
Jul 2022+5.5%
Aug 2022-8.0%
Sep 2022-11%
Oct 2022-2.5%
Nov 2022-31%
Dec 2022-0.16%
Jan 2023+25%2023
Feb 2023-8.4%
Mar 2023-16%
Apr 2023-7.7%
May 2023+55%
Jun 2023-19%
Jul 2023+3.1%
Aug 2023-17%
Sep 2023-25%
Oct 2023-16%
Nov 2023+59%
Dec 2023+34%
Jan 2024-4.9%2024
Feb 2024+106%
Mar 2024-6.9%
Apr 2024-21%
May 2024-25%
Jun 2024-9.7%
Jul 2024+8.9%
Aug 2024+34%
Sep 2024-19%
Oct 2024+11%
Nov 2024-11%
Dec 2024-21%
Jan 2025-21%2025
Feb 2025-28%
Mar 2025-21%
Apr 2025+7.8%
May 2025-51%
Jun 2025-1.7%
Jul 2025+49%
Aug 2025-13%
Sep 2025-2.7%
Oct 2025-9.2%
Nov 2025+25%
Dec 2025+11%
Jan 2026-6.6%2026
Feb 2026+51%
Mar 2026-9.1%
Apr 2026-4.3%
May 2026+22%
Jun 2026+1.5%
Jul 2026-2.2%
Aug 2026+101%
Sep 2026+81%
Oct 2026-8.1%
Iovance Biotherapeutics Inc. returns by calendar month#
Every month of every year since 2011, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -8.10% — 9th of 16 Octobers since 2011 at the last close; the average October returned -3.5%.
| Month | −250%0+250% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | -4.1% | -5.2% | 31% | +94.4% 2018 | -53.0% 2014 | |
| Feb | +11.5% | +7.5% | 63% | +105.8% 2024 | -27.5% 2025 | |
| Mar | -1.1% | -7.1% | 19% | +71.0% 2014 | -25.0% 2013 | |
| Apr | -6.4% | -6.0% | 31% | +19.9% 2019 | -66.7% 2013 | |
| May | +2.5% | -3.2% | 44% | +150.0% 2013 | -55.4% 2022 | |
| Jun | +3.4% | -5.7% | 44% | +63.6% 2022 | -60.0% 2013 | |
| Jul | +21.3% | +5.7% | 69% | +250.0% 2013 | -20.4% 2017 | |
| Aug | +2.2% | -9.0% | 31% | +100.7% 2026 | -27.9% 2011 | |
| Sep | -0.6% | -2.0% | 38% | +81.4% 2026 | -36.4% 2018 | |
| Oct | -3.5% | -2.5% | 40% | +25.0% 2011 | -27.5% 2013 | |
| Nov | +10.7% | +8.0% | 67% | +77.3% 2013 | -31.5% 2022 | |
| Dec | +3.3% | +4.5% | 60% | +33.9% 2023 | -42.1% 2012 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from IOVA's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Iovance Biotherapeutics Inc.'s average monthly return?
- Iovance Biotherapeutics Inc. (IOVA) has averaged about 3.19% per month, positive in roughly 44% of months. The best month was Jul 2013 (+250.0%) and the worst was Apr 2013 (-66.7%).
More on Iovance Biotherapeutics Inc.
By month for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100